on INNATE PHARMA (EPA:IPH)
Innate Pharma Announces 2025 Half-Year Results Conference Call
Innate Pharma, listed on Euronext Paris and Nasdaq, will hold a conference call on September 17, 2025. This meeting will present financial results and portfolio progress for the first half of 2025. Keynote speakers will be Jonathan Dickinson, Sonia Quaratino, Yannis Morel, and Frédéric Lombard. The call will be accessible live via an online link and will be archived for 90 days on the company's website.
Specializing in cancer immunotherapies, Innate Pharma develops innovative treatments such as NK Cell Engagers and other monoclonal antibodies. These strategies are particularly targeted at solid cancers and T-cell lymphomas. A partner of Sanofi and AstraZeneca, the company continues to innovate in the field of biotechnology.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all INNATE PHARMA news